Creating a database to understand the effects of KCNH2 gene variants in Long QT Syndrome
Official title: Building of a Diagnostic/Prognostic Database by High-throughput Multiplexed Assays for Human ERG Variant Effects
Run by Nantes University Hospital · NCT06087367 · Data updated 2026-11-12
This study is trying to create a database to help understand how changes in the KCNH2 gene affect people with Long QT Syndrome and improve their diagnosis and treatment.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Nantes University Hospital Academic / other |
| Locations | 2 sites (Nantes, Loire-atlantique and 1 other locations) |
| Status | Recruiting |
| Started | September 20, 2021 |
| Main results expected | December 31, 2023 |
| Study ends | March 24, 2026 |
| Registry record updated | May 23, 2025 |
| Trial ID | NCT06087367 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients who carry a mutation in the KCNH2 gene.
✕Probably not a fit
Patients who do not have a mutation in the KCNH2 gene or refuse to participate in the research will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to build a comprehensive diagnostic and prognostic database focused on the effects of variants in the KCNH2 gene, which is linked to Long QT Syndrome. By utilizing Next Generation Sequencing, the study will analyze numerous KCNH2 variants to determine their functional significance and impact on heart rhythm disorders. The goal is to enhance understanding of these variants' pathogenicity, which is essential for accurate diagnosis and treatment planning for affected patients.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic accuracy and personalized treatment options for patients with Long QT Syndrome.
How similar studies have gone: While there is ongoing research into KCNH2 variants, this specific approach to building a comprehensive database is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients carrier of a mutation in KCNH2 gene Exclusion Criteria: * Patients who refuse to take part to research
Where it's running
-
Nantes university hospital
Nantes, Loire-atlantique, France Recruiting -
Hôpital Bichat - Claude Bernard
Paris, France Recruiting
Study contacts
- Study coordinator: Vincent Probst, PUPH
- Email: vincent.probst@chu-nantes.fr
- Phone: 0240165279
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-powered ECG tools to detect deadly heart rhythms and ICI-related myocarditis
Researchers are testing AI-powered analysis of ECG data to see if it can help flag dangerous arrhythmias and myocarditis in people who may be affected by immune checkpoint inhibitors.
-
Monitoring Long QT Syndrome with Wearable Devices
This study tests if using wearable devices to track heart activity can help adults with Long QT syndrome manage their condition better.
-
Registry for hereditary cardiovascular diseases in Brazil
This study is trying to create a registry of Brazilian patients with hereditary heart diseases to see how common certain genetic changes are in people with these conditions.
-
Long-term outcomes for patients with cardiac arrhythmias
This study looks at how well treatments for heart rhythm problems work over time and what factors might affect their success for patients with conditions like atrial fibrillation and ventricular tachycardia.
-
Comparing direct and indirect methods for screening family members at risk for genetic conditions
This study is testing two ways to reach out to family members at risk for Long QT Syndrome and Familial Hypercholesterolemia to see which method helps them get screened better, while also offering free genetic testing and counseling.
-
Comparing continuous and intermittent heart monitoring methods
This study is testing a new continuous heart monitoring patch to see if it works better than regular heart tests for patients with certain heart conditions who are taking medications that might cause problems.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.